Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Touyun Tech Group ( (HK:1332) ) has shared an announcement.
Touyun Biotech Group Limited has announced several strategic measures to address a disclaimer of opinion on its financial statements. These measures include launching new health products, securing financial support from directors and shareholders, obtaining new loans, and negotiating loan extensions. Additionally, the company is exploring options to increase working capital through asset disposals and enhancing product distribution through partnerships with supermarket chains and collaborations with Key Opinion Leaders. These initiatives aim to resolve uncertainties related to the company’s going concern status and improve its financial stability.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates in the biotechnology industry, focusing on the development and distribution of health products. The company aims to expand its customer base and revenue streams by targeting various customer groups as health consciousness rises.
Average Trading Volume: 521,623
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$280.6M
Find detailed analytics on 1332 stock on TipRanks’ Stock Analysis page.